Linked Life Data

15985652

Source:http://linkedlifedata.com/resource/pubmed/id/15985652

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15985652rdf:typepubmed:Citationlld:pubmed
pubmed-article:15985652lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C0401925lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C0687028lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C0213238lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C1516698lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:15985652lifeskim:mentionsumls-concept:C2346714lld:lifeskim
pubmed-article:15985652pubmed:issue1lld:pubmed
pubmed-article:15985652pubmed:dateCreated2005-12-12lld:pubmed
pubmed-article:15985652pubmed:abstractTextPrevailing expression levels of aquaporin-2 (AQP2) mRNA play a major role in regulating AQP2 protein abundance. Here, we investigated whether AQP2 protein abundance is regulated at a posttranscriptional level as well. The expression levels of both AQP2 mRNA and protein increase in response to arginine vasopressin (AVP) in a concentration- and time-dependent manner in cultured immortalized mouse collecting duct principal cells (mpkCCD(cl4) cells). AVP washout from the medium of AVP-pretreated cells revealed that AQP2 mRNA expression progressively decreased over time, whereas AQP2 protein abundance first increased immediately after AVP washout and then gradually decreased over time. Inversely, increasing AVP concentration led to a time-dependent increase of AQP2 mRNA, whereas AQP2 protein abundance first decreased immediately after AVP supplementation and then gradually increased over time. These transient effects arose from altered V2-receptor activity because they could be abolished by SR-121463B, a specific V2-receptor antagonist. Although cycloheximide administration had no effect on transient alterations of AQP2 protein content, these effects were attenuated by administration of chloroquine, a lysosomal inhibitor, or lactacystin, a proteasomal inhibitor. Short-term inhibition of PKA activity significantly increased AQP2 protein abundance and blunted the transient alterations of AQP2 protein content induced by AVP washout and supplementation. In addition, phosphorylated AQP2 abundance increased immediately after AVP supplementation. These results indicate that in response to AVP AQP2 protein abundance in collecting duct principal cells is principally influenced by AQP2 mRNA content but is additionally regulated by PKA-dependent negative feedback acting on AQP2 protein degradation.lld:pubmed
pubmed-article:15985652pubmed:languageenglld:pubmed
pubmed-article:15985652pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15985652pubmed:citationSubsetIMlld:pubmed
pubmed-article:15985652pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15985652pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15985652pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15985652pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15985652pubmed:statusMEDLINElld:pubmed
pubmed-article:15985652pubmed:monthJanlld:pubmed
pubmed-article:15985652pubmed:issn1931-857Xlld:pubmed
pubmed-article:15985652pubmed:authorpubmed-author:NielsenSørenSlld:pubmed
pubmed-article:15985652pubmed:authorpubmed-author:HaslerUdoUlld:pubmed
pubmed-article:15985652pubmed:authorpubmed-author:MartinPierre-...lld:pubmed
pubmed-article:15985652pubmed:authorpubmed-author:FérailleEricElld:pubmed
pubmed-article:15985652pubmed:issnTypePrintlld:pubmed
pubmed-article:15985652pubmed:volume290lld:pubmed
pubmed-article:15985652pubmed:ownerNLMlld:pubmed
pubmed-article:15985652pubmed:authorsCompleteYlld:pubmed
pubmed-article:15985652pubmed:paginationF177-87lld:pubmed
pubmed-article:15985652pubmed:dateRevised2011-4-28lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:meshHeadingpubmed-meshheading:15985652...lld:pubmed
pubmed-article:15985652pubmed:year2006lld:pubmed
pubmed-article:15985652pubmed:articleTitlePosttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells.lld:pubmed
pubmed-article:15985652pubmed:affiliationService de Néphrologie, Fondation pour Recherches Médicales, 64 Ave. de la Roseraie, CH-1211, Genève 4, Switzerland.lld:pubmed
pubmed-article:15985652pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15985652pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15985652pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11827entrezgene:pubmedpubmed-article:15985652lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15985652lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15985652lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15985652lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15985652lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15985652lld:pubmed